Mimedx (MDXG) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Mimedx (MDXG) over the last 11 years, with Q3 2025 value amounting to $0.08.
- Mimedx's Debt to Equity fell 3391.32% to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.08, marking a year-over-year decrease of 3391.32%. This contributed to the annual value of $0.1 for FY2024, which is 7165.64% down from last year.
- Latest data reveals that Mimedx reported Debt to Equity of $0.08 as of Q3 2025, which was down 3391.32% from $0.09 recorded in Q2 2025.
- In the past 5 years, Mimedx's Debt to Equity ranged from a high of $586.91 in Q4 2021 and a low of -$8.27 during Q3 2021
- For the 5-year period, Mimedx's Debt to Equity averaged around $30.64, with its median value being $0.08 (2025).
- As far as peak fluctuations go, Mimedx's Debt to Equity tumbled by 37547.29% in 2021, and later surged by 158253.51% in 2023.
- Quarter analysis of 5 years shows Mimedx's Debt to Equity stood at $586.91 in 2021, then crashed by 100.46% to -$2.7 in 2022, then surged by 112.73% to $0.34 in 2023, then plummeted by 71.66% to $0.1 in 2024, then dropped by 21.83% to $0.08 in 2025.
- Its last three reported values are $0.08 in Q3 2025, $0.09 for Q2 2025, and $0.09 during Q1 2025.